Skip to main content
Top
Published in: Current Geriatrics Reports 3/2014

01-09-2014 | Geriatric Oncology (TM Wildes, Section Editor)

Models of Care in Geriatric Oncology

Authors: Allison Magnuson, William Dale, Supriya Mohile

Published in: Current Geriatrics Reports | Issue 3/2014

Login to get access

Abstract

The highest incidence of cancer occurs among older adults, and the approach to cancer treatment and supportive measures in this age group is continuously evolving. Incorporating geriatric assessment (GA) into the care of the older patient with cancer has been shown to be feasible and predictive of outcomes; there are unique aspects of the traditional geriatric domains that can be considered in this population. Geriatric assessment-guided interventions can also be developed to support patients during their treatment course. There are several existing models of incorporating geriatrics into oncology care, including a consultative geriatric assessment, a geriatrician “embedded” within an oncology clinic, and primary management by a dual-trained geriatric oncologist. Although the geriatric assessment is led by a geriatrician or geriatric oncologist, it is a true multidisciplinary assessment, and often includes evaluation by a physical therapist, occupational therapist, pharmacist, social worker, and nutritionist.
Literature
1.
2.
go back to reference Hutchins LF, Unger JM, Crowley JJ, Coltman Jr CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061–7.PubMedCrossRef Hutchins LF, Unger JM, Crowley JJ, Coltman Jr CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061–7.PubMedCrossRef
3.
go back to reference Wildiers H, Mauer M, Pallis A, et al. End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer–Alliance for Clinical Trials in Oncology–International Society Of Geriatric Oncology position article. J Clin Oncol. 2013;31(29):3711–8.PubMedCrossRef Wildiers H, Mauer M, Pallis A, et al. End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer–Alliance for Clinical Trials in Oncology–International Society Of Geriatric Oncology position article. J Clin Oncol. 2013;31(29):3711–8.PubMedCrossRef
4.••
go back to reference Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457–65. This article demonstrates the predictive ability of GA.PubMedCentralPubMedCrossRef Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457–65. This article demonstrates the predictive ability of GA.PubMedCentralPubMedCrossRef
5.
go back to reference O'Donovan A. Geriatric assessment for older adults with cancer: an international delphi study/an expert consensus panel on geriatric assessment interventions in oncology: the european perspective. J Geriatr Oncol. 2013;4(Supplement 1):S14–5.CrossRef O'Donovan A. Geriatric assessment for older adults with cancer: an international delphi study/an expert consensus panel on geriatric assessment interventions in oncology: the european perspective. J Geriatr Oncol. 2013;4(Supplement 1):S14–5.CrossRef
6.
go back to reference Dale W, Mohile SG, Eldadah BA, et al. Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst. 2012;104(8):581–9.PubMedCentralPubMedCrossRef Dale W, Mohile SG, Eldadah BA, et al. Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst. 2012;104(8):581–9.PubMedCentralPubMedCrossRef
7.
go back to reference Hurria A, Wildes T, Blair SL, et al. Senior adult oncology, version 2.2014: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(1):82–126.PubMed Hurria A, Wildes T, Blair SL, et al. Senior adult oncology, version 2.2014: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(1):82–126.PubMed
8.
go back to reference Ingram S, Seo PH, Martell RE, Clipp EC, Doyle ME, Montana GS, et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol. 2002;20(3):770–5.PubMedCrossRef Ingram S, Seo PH, Martell RE, Clipp EC, Doyle ME, Montana GS, et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol. 2002;20(3):770–5.PubMedCrossRef
9.
go back to reference Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005;104(9):1998–2005.PubMedCrossRef Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005;104(9):1998–2005.PubMedCrossRef
10.
go back to reference Hurria A. Incorporation of geriatric principles in oncology clinical trials. J Clin Oncol. 2007;25(34):5350–1.PubMedCrossRef Hurria A. Incorporation of geriatric principles in oncology clinical trials. J Clin Oncol. 2007;25(34):5350–1.PubMedCrossRef
11.
go back to reference Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494–502.PubMedCrossRef Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494–502.PubMedCrossRef
12.
go back to reference Extermann M, Aapro M. Assessment of the older cancer patient. Hematol Oncol Clin N Am. 2000;14(1):63–77. viii–ix.CrossRef Extermann M, Aapro M. Assessment of the older cancer patient. Hematol Oncol Clin N Am. 2000;14(1):63–77. viii–ix.CrossRef
13.
go back to reference Mohile SG, Bylow K, Dale W, et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer. 2007;109(4):802–10.PubMedCrossRef Mohile SG, Bylow K, Dale W, et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer. 2007;109(4):802–10.PubMedCrossRef
14.
go back to reference Koroukian SM, Murray P, Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol. 2006;24(15):2304–10.PubMedCrossRef Koroukian SM, Murray P, Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol. 2006;24(15):2304–10.PubMedCrossRef
15.
go back to reference Mohile SG, Xian Y, Dale W, et al. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst. 2009;101(17):1206–15.PubMedCentralPubMedCrossRef Mohile SG, Xian Y, Dale W, et al. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst. 2009;101(17):1206–15.PubMedCentralPubMedCrossRef
16.
go back to reference Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25(14):1824–31.PubMedCrossRef Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25(14):1824–31.PubMedCrossRef
17.••
go back to reference Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. Nov 9 2011. This article demonstrates predictive ability of GA. Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. Nov 9 2011. This article demonstrates predictive ability of GA.
18.
go back to reference Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin. 2010;60(2):120–32.PubMedCrossRef Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin. 2010;60(2):120–32.PubMedCrossRef
19.
go back to reference Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of adl: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.PubMedCrossRef Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of adl: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.PubMedCrossRef
20.
go back to reference Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.PubMedCrossRef Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.PubMedCrossRef
21.
go back to reference Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol Mar. 1994;49(2):M85–94.CrossRef Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol Mar. 1994;49(2):M85–94.CrossRef
22.
go back to reference Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.PubMed Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.PubMed
23.
go back to reference Repetto L, Comandini D, Mammoliti S. Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients. Crit Rev Oncol Hematol. 2001;37(2):147–52.PubMedCrossRef Repetto L, Comandini D, Mammoliti S. Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients. Crit Rev Oncol Hematol. 2001;37(2):147–52.PubMedCrossRef
24.
go back to reference Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol. 2006;24(10):1633–42.PubMedCrossRef Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol. 2006;24(10):1633–42.PubMedCrossRef
25.
go back to reference Gewandter JS, Fan L, Magnuson A, et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013;21(7):2059–66.PubMedCentralPubMedCrossRef Gewandter JS, Fan L, Magnuson A, et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013;21(7):2059–66.PubMedCentralPubMedCrossRef
26.
go back to reference Sheridan J, Walsh P, Kevans D, et al. Determinants of short- and long-term survival from colorectal cancer in very elderly patients. J Geriatr Oncol. May 17 2014. Sheridan J, Walsh P, Kevans D, et al. Determinants of short- and long-term survival from colorectal cancer in very elderly patients. J Geriatr Oncol. May 17 2014.
27.
go back to reference Jorgensen TLHJ, Land LH, Herrstedt J. Comorbidity and polypharmacy in elderly cancer patients: the significant on treatment outcome and tolerance. J Geriatr Oncol. 2010;1(2):87–102.CrossRef Jorgensen TLHJ, Land LH, Herrstedt J. Comorbidity and polypharmacy in elderly cancer patients: the significant on treatment outcome and tolerance. J Geriatr Oncol. 2010;1(2):87–102.CrossRef
28.
go back to reference Prithviraj GKKS, Margevicius S, Berger NA, Bagai R, Owusu C. Patient characteritics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012;3(3):228–37.PubMedCentralPubMedCrossRef Prithviraj GKKS, Margevicius S, Berger NA, Bagai R, Owusu C. Patient characteritics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012;3(3):228–37.PubMedCentralPubMedCrossRef
29.
go back to reference Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology group. Am J Med. 1980;69(4):491–7.PubMedCrossRef Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology group. Am J Med. 1980;69(4):491–7.PubMedCrossRef
30.
go back to reference Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol. 2011;29(27):3620–7.PubMedCrossRef Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol. 2011;29(27):3620–7.PubMedCrossRef
31.
go back to reference Aaldriks AA, van der Geest LG, Giltay EJ, et al. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol. 2013;4(3):218–26.PubMedCrossRef Aaldriks AA, van der Geest LG, Giltay EJ, et al. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol. 2013;4(3):218–26.PubMedCrossRef
32.
go back to reference Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc. 2004;52(10):1681–7.PubMedCrossRef Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc. 2004;52(10):1681–7.PubMedCrossRef
33.
go back to reference Gorin SS, Heck JE, Albert S, Hershman D. Treatment for breast cancer in patients with Alzheimer's disease. J Am Geriatr Soc. 2005;53(11):1897–904.PubMedCrossRef Gorin SS, Heck JE, Albert S, Hershman D. Treatment for breast cancer in patients with Alzheimer's disease. J Am Geriatr Soc. 2005;53(11):1897–904.PubMedCrossRef
34.
go back to reference Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst. 1996;88(15):1031–8.PubMedCrossRef Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst. 1996;88(15):1031–8.PubMedCrossRef
35.
go back to reference Luciani A, Jacobsen PB, Extermann M, et al. Fatigue and functional dependence in older cancer patients. Am J Clin Oncol. 2008;31(5):424–30.PubMedCrossRef Luciani A, Jacobsen PB, Extermann M, et al. Fatigue and functional dependence in older cancer patients. Am J Clin Oncol. 2008;31(5):424–30.PubMedCrossRef
36.
go back to reference Freyer G, Geay JF, Touzet S, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol ESMO. 2005;16(11):1795–800.CrossRef Freyer G, Geay JF, Touzet S, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol ESMO. 2005;16(11):1795–800.CrossRef
37.•
go back to reference Caillet P, Canoui-Poitrine F, Vouriot J, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol. 2011;29(27):3636–42. This article demonstrates that GA influences decision-making.PubMedCrossRef Caillet P, Canoui-Poitrine F, Vouriot J, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol. 2011;29(27):3636–42. This article demonstrates that GA influences decision-making.PubMedCrossRef
38.
go back to reference Horgan AM, Leighl NB, Coate L, et al. Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol. Mar 17 2011. Horgan AM, Leighl NB, Coate L, et al. Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol. Mar 17 2011.
39.
go back to reference Saliba D, Orlando M, Wenger NS, Hays RD, Rubenstein LZ. Identifying a short functional disability screen for older persons. J Gerontol A Biol Sci Med Sci. 2000;55(12):M750–6.PubMedCrossRef Saliba D, Orlando M, Wenger NS, Hays RD, Rubenstein LZ. Identifying a short functional disability screen for older persons. J Gerontol A Biol Sci Med Sci. 2000;55(12):M750–6.PubMedCrossRef
40.
go back to reference Saliba D, Elliott M, Rubenstein LZ, et al. The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691–9.PubMedCrossRef Saliba D, Elliott M, Rubenstein LZ, et al. The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691–9.PubMedCrossRef
41.
go back to reference Min LC, Elliott MN, Wenger NS, Saliba D. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc. 2006;54(3):507–11.PubMedCrossRef Min LC, Elliott MN, Wenger NS, Saliba D. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc. 2006;54(3):507–11.PubMedCrossRef
42.
go back to reference Min L, Yoon W, Mariano J, et al. The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc. 2009;57(11):2070–6.PubMedCentralPubMedCrossRef Min L, Yoon W, Mariano J, et al. The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc. 2009;57(11):2070–6.PubMedCentralPubMedCrossRef
43.
go back to reference Luciani A, Ascione G, Bertuzzi C, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol. 2010;28(12):2046–50.PubMedCrossRef Luciani A, Ascione G, Bertuzzi C, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol. 2010;28(12):2046–50.PubMedCrossRef
44.
go back to reference Steverink NSJ, Schuurmans H, et al. Measuring frailty: developing and testing the GFI (Groningen Frailty Indicator). Gerontologist. 2001;41:236. Steverink NSJ, Schuurmans H, et al. Measuring frailty: developing and testing the GFI (Groningen Frailty Indicator). Gerontologist. 2001;41:236.
45.
go back to reference Metzelthin SF, Daniels R, van Rossum E, de Witte L, van den Heuvel WJ, Kempen GI. The psychometric properties of three self-report screening instruments for identifying frail older people in the community. BMC Public Health. 2010;10:176.PubMedCentralPubMedCrossRef Metzelthin SF, Daniels R, van Rossum E, de Witte L, van den Heuvel WJ, Kempen GI. The psychometric properties of three self-report screening instruments for identifying frail older people in the community. BMC Public Health. 2010;10:176.PubMedCentralPubMedCrossRef
47.
go back to reference Aaldriks AA, Maartense E, le Cessie S, et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol. 2011;79(2):205–12.PubMedCrossRef Aaldriks AA, Maartense E, le Cessie S, et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol. 2011;79(2):205–12.PubMedCrossRef
48.
go back to reference Soubeyran P BC, Goyard J, et al. Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project. J Clin Oncol. 2011;29 (suppl; abstr 9001). Soubeyran P BC, Goyard J, et al. Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project. J Clin Oncol. 2011;29 (suppl; abstr 9001).
49.
go back to reference Magnuson AAJ, Dale W, Fan L, Mohile S. Feasibility of Integrating Comprehensive Geriatric Assessment-Driven Interventions into Standard Oncology Practice in Real Time. Paper presented at: Symposium on Geriatric Assessment in the Oncology Setting and Related Issues in Geriatric Oncology 2011; Toronto, Canada. Magnuson AAJ, Dale W, Fan L, Mohile S. Feasibility of Integrating Comprehensive Geriatric Assessment-Driven Interventions into Standard Oncology Practice in Real Time. Paper presented at: Symposium on Geriatric Assessment in the Oncology Setting and Related Issues in Geriatric Oncology 2011; Toronto, Canada.
50.
go back to reference Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114(512):797–811.PubMedCrossRef Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114(512):797–811.PubMedCrossRef
51.
go back to reference Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRef Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRef
Metadata
Title
Models of Care in Geriatric Oncology
Authors
Allison Magnuson
William Dale
Supriya Mohile
Publication date
01-09-2014
Publisher
Springer US
Published in
Current Geriatrics Reports / Issue 3/2014
Electronic ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-014-0095-4

Other articles of this Issue 3/2014

Current Geriatrics Reports 3/2014 Go to the issue

Geriatric Oncology (TM Wildes, Section Editor)

Falls in Older Adults with Cancer

Geriatric Oncology (TM Wildes, Section Editor)

Multiple Myeloma in Older Adults

Geriatric Oncology (TM Wildes, Section Editor)

Colon Cancer in Older Adults: A Primer for Geriatricians

Geriatric Oncology (TM Wildes, Section Editor)

Lung Cancer in Older Adults

Physical Therapy and Rehabilitation (J Richardson, Section Editor)

Aging, Fatigue, and Fatigability: Implications for Occupational and Physical Therapists

Geriatric Oncology (TM Wildes, Section Editor)

Endometrial Cancer in the Elderly

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.